Press Release 2020

September 1, 2020

 

OCULIS ESTABLISHES PRESENCE IN U.S. AND APPOINTS SYLVIA CHEUNG AS CHIEF FINANCIAL OFFICER 

August 10, 2020

 

OCULIS REPORTS POSITIVE TOP-LINE DATA FROM SKYGGN (PHASE 2) TRIAL WITH OCS-01 FOR TREATING INFLAMMATION AND PAIN FOLLOWING CATARACT SURGERY

July 27, 2020

 

OCULIS ANNOUNCES SUCCESSFUL END-OF-PHASE 2 MEETING WITH THE FDA FOR OCS-01 IN TWO OPHTHALMOLOGY INDICATIONS